S
Stephen G. Ellis
Researcher at Cleveland Clinic
Publications - 668
Citations - 67828
Stephen G. Ellis is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 127, co-authored 655 publications receiving 65073 citations. Previous affiliations of Stephen G. Ellis include Scripps Health & Brown University.
Papers
More filters
Journal ArticleDOI
Spectrum of surgical risk for left main coronary stenoses: benchmark for potentially competing percutaneous therapies
TL;DR: To determine the spectrum of surgical outcome among patients with left main trunk coronary stenoses, potential covariates of in-hospital and 3-year mortality for a consecutive series of patients without prior coronary artery bypass grafting treated at the authors' institution from January 1990 to December 1995 are analyzed.
Journal ArticleDOI
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial
Ameet Bakhai,Gregg W. Stone,Elizabeth Mahoney,Tara A. Lavelle,Chunxue Shi,Ronna H. Berezin,Betsy J. Lahue,Mary Ann Clark,Michael J. Lacey,Mary E. Russell,Stephen G. Ellis,James B. Hermiller,David A. Cox,David J. Cohen,David J. Cohen,Taxus-Iv Investigators +15 more
TL;DR: Treatment with PES led to substantial reductions in the need for repeat revascularization while increasing 1-year costs only modestly in the TAXUS-IV trial, and the cost-effectiveness ratio for PES compares reasonably with that for other treatments that reduce coronary restenosis, including alternative drug-eluting stent platforms.
Journal ArticleDOI
Reduction in Myocardial Infarct Size by Basic Fibroblast Growth Factor After Temporary Coronary Occlusion in a Canine Model
Mark C.G Horrigan,Andrew I. MacIsaac,Francesca A. Nicolini,D. G. Vince,Pauline Lee,Stephen G. Ellis,Eric J. Topol +6 more
TL;DR: The data suggest that bFGF mediates myocardial salvage independently of angiogenesis and that reperfusion after infarction may attenuate the stimulus for neovascularization.
Journal ArticleDOI
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.
Fernando A. Cura,Deepak L. Bhatt,A. Michael Lincoff,Samir R. Kapadia,Philippe L. L’Allier,Khaled M. Ziada,Katherine E. Wolski,David J. Moliterno,Sorin J. Brener,Stephen G. Ellis,Eric J. Topol +10 more
TL;DR: The combination of stenting and abciximab during percutaneous coronary interventions for patients with angiographically complex lesions confers additive long-term benefit with respect to death, myocardial infarction, and target vessel revascularization.
Journal ArticleDOI
Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure
TL;DR: Transient, uncomplicated in-laboratory vessel closure per se does not have an adverse long-term effect, however, a concomitant elevation of postprocedure cardiac enzymes has an important and significant adverse effect on long- term outcome.